Genova Biotherapeutics, Inc. GVBP Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Genova Biotherapeutics, Inc. GVBP Company Overview 

Stock Message Board http://investorshangout.com/search?q=GVBP&...mp;yt1=Go!

Genova Biotherapeutics, Inc. GVBP Current Price and Quotes
Last Price


Genova Biotherapeutics, Inc. GVBP
Company Information

1461 A. First Ave.
#360
New York, NY 10021-2209

Website: http://www.genovabio.com
Phone: 646-845-1920
Email: investorrelations@genovabio.com

Genova Biotherapeutics, Inc. GVBP
GENova is a biotechnological drug development company with a strict focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings.

Genova Biotherapeutics, Inc. GVBP
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2009 10-K
CIK 0001364587
Fiscal Year End 12/31
OTC Marketplace Grey Market
Profile Data

SIC - Industry Classification 5122 - Drugs, proprietaries, and sundries
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Aaron Whiteman CEO, CFO
Hyunho Jin Secretary
John Savin Vice President, VP, Bus. Dev. & Corp. Rel.
Company Directors

Dirk Holzhauer
Company Notes

Formerly=Kinder Travel, Inc. until 7-2009
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Genova Biotherapeutics, Inc. GVBP
GVBP Security Details

Share Structure

Market Value1 $33,125 a/o Sep 12, 2013
Shares Outstanding 331,250,000 a/o Jul 13, 2009
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Security Notes

12(k) Suspended by the SEC 9:30 a.m. September 23, 2009 and terminating at 11:59 p.m. on October 6, 2009
Capital Change=shs increased by 125 for 1 split, payable upon surrender.. Pay date=07/13/2009.
Short Selling Data

Short Interest 0 (-100%)
Mar 28, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Action Stock Transfer Corporation

Genova Biotherapeutics, Inc. GVBP Recent News

Genova Biotherapeutics, Inc. GVBP Financials
GVBP


GVBP Genova Biotherapeutics, Inc. Research DD Guide

GVBP Genova Biotherapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=GVBP&...mp;yt0=Go!
GVBP Genova Biotherapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/GVBP/quote
GVBP Genova Biotherapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/GVBP/chart
GVBP Genova Biotherapeutics, Inc. Company Info http://www.otcmarkets.com/stock/GVBP/company-info
GVBP Genova Biotherapeutics, Inc. Recent News http://www.otcmarkets.com/stock/GVBP/news
GVBP Genova Biotherapeutics, Inc. Financials http://www.otcmarkets.com/stock/GVBP/financials
GVBP Genova Biotherapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/GVBP/filings
GVBP Genova Biotherapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/GVBP/short-sales
GVBP Genova Biotherapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/GVBP/insider-transactions
GVBP Genova Biotherapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/GVBP/research
GVBP Genova Biotherapeutics, Inc. Summary http://finance.yahoo.com/q?s=GVBP
GVBP Genova Biotherapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=GVBP+Historical+Prices
GVBP Genova Biotherapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=GVBP
GVBP Genova Biotherapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=GVBP+Basic+Chart
GVBP Genova Biotherapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GVBP+Basic+Tech.+Analysis
GVBP Genova Biotherapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=GVBP+Headlines
GVBP Genova Biotherapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=GVBP+Press+Releases
GVBP Genova Biotherapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=GVBP+Profile
GVBP Genova Biotherapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=GVBP+Key+Statistics
GVBP Genova Biotherapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=GVBP+Industry
GVBP Genova Biotherapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=GVBP+Major+Holders
GVBP Genova Biotherapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=GVBP+Insider+Transactions
GVBP Genova Biotherapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=GVBP+Insider+Roster
GVBP Genova Biotherapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=GVBP
GVBP Genova Biotherapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=GVBP
GVBP Genova Biotherapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=GVBP+Cash+Flow&annual
GVBP Genova Biotherapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/GVBP
GVBP Genova Biotherapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/GVBP
GVBP Genova Biotherapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/GVBP:US
GVBP Genova Biotherapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=GVBP
GVBP Genova Biotherapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=GVBP
GVBP Genova Biotherapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/GVBP
GVBP Genova Biotherapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=GVBP
GVBP Genova Biotherapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/GVBP/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CopperWood Senior Living Revives Historic Campus

Updated Category News Views 11

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 18

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 85

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
Digital Art Sparks Future City Visions in Beijing

Updated Category News Views 8

Beijing's Bold Digital Art Venture: A New Era in Creativity Ever felt the jittery buzz of innovation on the cutting edge? That's exactly what visitors experienced in Beijing's 'Spiritual Land: Future World of Inspiration' exhibition at the BOE Yiyun Digital Art Center. Set against the backdrop of the sprawling metropolis, this joint effort between Beijing and Linz aims to...

Continue Reading
XREAL AURA: A New Era of Wired XR Glasses

Updated Category News Views 60

Pioneering the XR Frontier Welcome to another day under the sun of cutting-edge tech, where XREAL's striking a chord with its new wired XR glasses—AURA. First off, don't let the tangled history of tech hype get to you. In the wild world of extended reality, we've seen plenty of flash, not enough substance. But XREAL's hitting the market with AURA, and I gotta say,...

Continue Reading
Hershey's Sweet Results: 2026 Earnings Soar

Updated Category News Views 75

Hershey's 2026 Q3 Financial Performance: A Closer Look At the end of September, The Hershey Company (NYSE: HSY) dished out some eye-popping numbers for their third quarter. With a net sales increase of 3.0%, they clocked in at $3,275.5 million. More importantly, earnings per share-diluted shot up by a whopping 111.8%, landing at $2.88. Clearly, Hershey’s strategic moves...

Continue Reading
Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

Updated Category News Views 0

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

Continue Reading
DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 79

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
Direxion Targets Anthropic's IPO with Bold New ETFs

Updated Category News Views 17

Anthropic's IPO Sparks Direxion's Latest ETF Moves Alright, folks, Anthropic's public filing for an IPO isn't just turning heads—it's lighting up the trading floor! Following this buzz, Direxion grabs its chance to unleash two new ETFs designed to seize on Anthropic's rollercoaster debut. We're talking about the Direxion Daily Anthropic Bull 2X ETF (ANTO) and the...

Continue Reading
GARDANT Expands Reach with International Partnership

Updated Category News Views 0

GARDANT Global's Strategic Expansion Well, today we saw GARDANT Global make a move that screams ambition. They’re hooking up with International Offset Corporation (IOC) to muscle up their game in the murky waters of government procurement. Why does this matter? Because it's all about who gets the contracts, and with GARDANT’s newfound reach, they’re not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Marex Group Faces Class Action Lawsuit Amid Serious Allegations

Updated Category News Views 293

Marex Group In the Spotlight The Marex Group, operating under the ticker symbol MRX, has recently come under scrutiny due to allegations of serious misconduct. Investors who have incurred significant losses are now facing the deadline to file lead plaintiff applications regarding a class action lawsuit. Key Details of the Class Action Marex Group plc, prominently...

Continue Reading
Genesis Shines Bright with Platinum Award for CSR Initiatives

Updated Category News Views 160

Genesis Shines Bright with Platinum Award for CSR Initiatives Genesis has recently been recognized for its outstanding corporate social responsibility efforts, particularly its mini-pitch initiative in collaboration with U.S. Soccer Foundation. This remarkable achievement showcases the company's unwavering commitment to empowering youth and fostering community engagement....

Continue Reading
Protext Mobility Expands Advisory Board with Key Leaders

Updated Category News Views 122

Protext Mobility Strengthens Advisory Board to Drive Growth Protext Mobility, Inc. (OTC: TXTM), a forward-thinking player in the biotechnology and alternative wellness space, has recently expanded its Advisory Board. This strategic decision comes as part of their ongoing commitment to innovation and transparency in operations. Formation of the Advisory Board Launched just...

Continue Reading
Avista Corp. Announces Q4 Earnings Call for 2024 Results

Updated Category News Views 101

Avista Corp. to Host Fourth Quarter 2024 Earnings Call Avista Corp. is set to share insights regarding their fourth quarter results for 2024 through a conference call and webcast. Scheduled for an early morning session on a Wednesday, this opportunity will allow stakeholders to engage directly with the company's financial updates and key operational highlights. Details of...

Continue Reading
Frontline plc Announces Q2 2024 Presentation Details

Updated Category News Views 112

Frontline plc's Second Quarter 2024 Presentation Frontline plc is set to announce its results for the second quarter of 2024. This eagerly awaited presentation will be held via webcast and conference call, providing investors and stakeholders with essential insights into the company's recent performance. Key Information About the Presentation The upcoming presentation...

Continue Reading